Douglas Beck
2013 - RELMADA THERAPEUTICS
In 2013, Douglas Beck earned a total compensation of $198.1K as Chief Financial Officer at RELMADA THERAPEUTICS.
Compensation breakdown
| Option Awards | $181,391 |
|---|---|
| Salary | $16,667 |
| Total | $198,058 |
Beck received $181.4K in option awards, accounting for 92% of the total pay in 2013.
Beck also received $16.7K in salary.
Rankings
In 2013, Douglas Beck's compensation ranked 11,618th out of 12,286 executives tracked by ExecPay. In other words, Beck earned more than 5.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,618 out of 12,286 | 5th |
Division Manufacturing | 4,362 out of 4,612 | 5th |
Major group Chemicals And Allied Products | 1,386 out of 1,466 | 6th |
Industry group Drugs | 1,102 out of 1,160 | 5th |
Industry Pharmaceutical Preparations | 850 out of 890 | 5th |
Source: SEC filing on November 17, 2014.
Beck's colleagues
We found one more compensation record of an executive who worked with Douglas Beck at RELMADA THERAPEUTICS in 2013.
2013
Sergio Traversa
RELMADA THERAPEUTICS